Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Single-dose rituximab as induction in renal transplantation.

van den Hoogen MW, Hilbrands LB.

Transplantation. 2010 May 27;89(10):1295; author reply 1295. doi: 10.1097/TP.0b013e3181d368c6. No abstract available.

PMID:
20555227
[PubMed - indexed for MEDLINE]
2.

Rituximab in pediatric renal transplantation: a treatment for allograft rejection with B-cell infiltrates?

Zand MS.

Am J Transplant. 2008 Dec;8(12):2489-90. doi: 10.1111/j.1600-6143.2008.02454.x. No abstract available.

PMID:
19032220
[PubMed - indexed for MEDLINE]
Free Article
3.

A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.

Zarkhin V, Li L, Kambham N, Sigdel T, Salvatierra O, Sarwal MM.

Am J Transplant. 2008 Dec;8(12):2607-17. doi: 10.1111/j.1600-6143.2008.02411.x. Epub 2008 Sep 18.

PMID:
18808404
[PubMed - indexed for MEDLINE]
Free Article
4.

BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection.

Zarkhin V, Li L, Sarwal MM.

Transplantation. 2009 Nov 27;88(10):1229-30. doi: 10.1097/TP.0b013e3181bbba1a. No abstract available.

PMID:
19935379
[PubMed - indexed for MEDLINE]
5.

Rituximab for humoral rejection after kidney transplantation: an update.

Rostaing L, Guilbeau-Frugier C, Kamar N.

Transplantation. 2009 Apr 27;87(8):1261. doi: 10.1097/TP.0b013e31819f627a. No abstract available.

PMID:
19384176
[PubMed - indexed for MEDLINE]
6.

Pharmacodynamics of rituximab in kidney allotransplantation.

Genberg H, Hansson A, Wernerson A, Wennberg L, Tydén G.

Am J Transplant. 2006 Oct;6(10):2418-28. Epub 2006 Aug 21.

PMID:
16925569
[PubMed - indexed for MEDLINE]
Free Article
7.

B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.

Pescovitz MD.

Clin Transplant. 2006 Jan-Feb;20(1):48-54. Review.

PMID:
16556153
[PubMed - indexed for MEDLINE]
8.

More on B-cell-depleting induction therapy and acute cellular rejection.

van den Hoogen MW, Hilbrands LB.

N Engl J Med. 2009 Sep 17;361(12):1215; author reply 1215-6. No abstract available.

PMID:
19771606
[PubMed - indexed for MEDLINE]
9.

Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab.

Lehnhardt A, Mengel M, Pape L, Ehrich JH, Offner G, Strehlau J.

Am J Transplant. 2006 Apr;6(4):847-51.

PMID:
16539643
[PubMed - indexed for MEDLINE]
Free Article
10.

B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.

Thaunat O, Patey N, Gautreau C, Lechaton S, Fremeaux-Bacchi V, Dieu-Nosjean MC, Cassuto-Viguier E, Legendre C, Delahousse M, Lang P, Michel JB, Nicoletti A.

Transplantation. 2008 Jun 15;85(11):1648-53. doi: 10.1097/TP.0b013e3181735723.

PMID:
18551073
[PubMed - indexed for MEDLINE]
11.

A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.

Kamburova EG, Koenen HJ, Borgman KJ, ten Berge IJ, Joosten I, Hilbrands LB.

Am J Transplant. 2013 Jun;13(6):1503-11. doi: 10.1111/ajt.12220. Epub 2013 Apr 9.

PMID:
23570303
[PubMed - indexed for MEDLINE]
Free Article
12.

Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.

Mitsuhata N, Fujita R, Ito S, Mannami M, Keimei K.

Transplantation. 2005 Nov 15;80(9):1355. No abstract available.

PMID:
16314808
[PubMed - indexed for MEDLINE]
13.

Drug insight: rituximab in renal disease and transplantation.

Salama AD, Pusey CD.

Nat Clin Pract Nephrol. 2006 Apr;2(4):221-30. Review.

PMID:
16932428
[PubMed - indexed for MEDLINE]
14.

Blocking of costimulation prevents kidney graft rejection in rhesus monkeys.

Ossevoort MA, Ringers J, Boon L, Lorré K, van den Hout Y, Kuhn EM, de Boer M, Jonker M, de Waele P.

Transplant Proc. 1998 Aug;30(5):2165-6. No abstract available.

PMID:
9723429
[PubMed - indexed for MEDLINE]
15.

[B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?].

Atzeni F, Sarzi-Puttini P.

Reumatismo. 2010 Apr-Jun;62(2):87-8. Italian. No abstract available.

PMID:
20657883
[PubMed - indexed for MEDLINE]
16.

A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection.

Mulley WR, Hudson FJ, Tait BD, Skene AM, Dowling JP, Kerr PG, Kanellis J.

Transplantation. 2009 Jan 27;87(2):286-9. doi: 10.1097/TP.0b013e31819389cc.

PMID:
19155986
[PubMed - indexed for MEDLINE]
17.

Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.

Tanaka Y.

Intern Med. 2007;46(16):1313-5. Epub 2007 Aug 15. No abstract available.

PMID:
17704614
[PubMed - indexed for MEDLINE]
Free Article
18.

B-cell-depleting induction therapy and acute cellular rejection.

Clatworthy MR, Watson CJ, Plotnek G, Bardsley V, Chaudhry AN, Bradley JA, Smith KG.

N Engl J Med. 2009 Jun 18;360(25):2683-5. doi: 10.1056/NEJMc0808481. No abstract available.

PMID:
19535812
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

More on B-cell-depleting induction therapy and acute cellular rejection.

Tydén G, Mjörnstedt L, Ekberg H.

N Engl J Med. 2009 Sep 17;361(12):1214-5; author reply 1215-6. doi: 10.1056/NEJMc091454. No abstract available.

PMID:
19759386
[PubMed - indexed for MEDLINE]
Free Article
20.

Induction therapy in pediatric renal transplant recipients: an overview.

Moudgil A, Puliyanda D.

Paediatr Drugs. 2007;9(5):323-41. Review.

PMID:
17927304
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk